tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
AbbVie announces FDA approval of Epkinly in combo with rituximab, lenalidomide
PremiumThe FlyAbbVie announces FDA approval of Epkinly in combo with rituximab, lenalidomide
12d ago
AbbVie says new Lupron Depot strength receives Health Canada Approval
Premium
The Fly
AbbVie says new Lupron Depot strength receives Health Canada Approval
14d ago
Mesoblast appoints James O’Brien as CFO
Premium
The Fly
Mesoblast appoints James O’Brien as CFO
14d ago
AbbVie ending partnership with Calico Life Sciences, STAT reports
PremiumThe FlyAbbVie ending partnership with Calico Life Sciences, STAT reports
18d ago
GH Research price target lowered to $35 from $40 at H.C. Wainwright
Premium
The Fly
GH Research price target lowered to $35 from $40 at H.C. Wainwright
20d ago
AbbVie price target raised to $220 from $195 at UBS
Premium
The Fly
AbbVie price target raised to $220 from $195 at UBS
23d ago
AbbVie price target raised to $260 from $250 at JPMorgan
PremiumThe FlyAbbVie price target raised to $260 from $250 at JPMorgan
28d ago
AbbVie price target lowered to $235 from $240 at Citi
Premium
The Fly
AbbVie price target lowered to $235 from $240 at Citi
28d ago
AbbVie price target raised to $261 from $255 at Morgan Stanley
Premium
The Fly
AbbVie price target raised to $261 from $255 at Morgan Stanley
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100